1.27
price up icon3.25%   0.04
after-market After Hours: 1.18 -0.09 -7.09%
loading
X T L Biopharmaceuticals Ltd Adr stock is traded at $1.27, with a volume of 18,872. It is up +3.25% in the last 24 hours and down -7.52% over the past month. XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
See More
Previous Close:
$1.23
Open:
$1.0304
24h Volume:
18,872
Relative Volume:
2.42
Market Cap:
$11.19M
Revenue:
-
Net Income/Loss:
$-2.25M
P/E Ratio:
-3.175
EPS:
-0.4
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
-7.52%
6M Performance:
-45.96%
1Y Performance:
-59.16%
1-Day Range:
Value
$0.9208
$1.40
1-Week Range:
Value
$0.9208
$1.40
52-Week Range:
Value
$0.9208
$3.3135

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name
Name
X T L Biopharmaceuticals Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
4
Name
Twitter
@xtlbio
Name
Next Earnings Date
2024-05-24
Name
Latest SEC Filings
Name
XTLB's Discussions on Twitter

Compare XTLB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
XTLB
X T L Biopharmaceuticals Ltd Adr
1.27 11.19M 0 -2.25M 0 -0.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades

Date Action Analyst Rating Change
May-08-15 Initiated H.C. Wainwright Buy

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Cap:     |  Volume (24h):